Novo Nordisk Pharmatech lands record profits in 2020

Novo Nordisk-owned company Novo Nordisk Pharmatech landed record profits in 2020. The firm's soon-to-be-former managing director reasons that this owes to solid advances in two product groups in particular.

Novo Nordisk Pharmatech Managing Director Rasmus Hother le Fevre | Photo: Gregers Tycho/ERH

Novo Nordisk' supply-focused subsidiary Novo Nordisk Pharmatech came out of 2020 with a record profit, according to the 2020 annual financial report for the latter.

The end result amounted to DKK 114.9m (USD 18.7m), which adds up to an 18 percent increase compared with the year before, when the matching result was DKK 97.3m.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs